HealthNewsReview.org | Independent Expert Reviews of News Stories | Holding Health and Medical Journalism Accountable

Silent heart attacks: What you don’t know could kill you

April 21, 2009

Read The Story
RATING:

This segment on MRI to help assess heart disease risk could have been much improved with just a few additional statements. The reporter did try, at least, to inject some cautious interpretation.

Our Review Summary

This segment on the use of MRI to help assess heart disease risk could have been much improved with just a few additional statements.

  • It needed an independent expert to put the new research into the context of existing methods of predicting heart risk.
  • It didn’t discuss costs.
  • It didn’t discuss clear potential harms that were mentioned in the journal article upon which the story was based.
  • It didn’t quantify “silent heart attack” prevalence or potential benefits of the MRI approach in the most meaningful way.
  • It didn't mention that the researchers in the study in question hold a patent to the machine used in the study.

The anchor twice provided openings that may have led to overinterpretation of the findings, but the correspondent resisted admirably both times.  And to her credit, the reporter did try, at least, to inject some cautious interpretation.  


 

Click on Criteria for definitions.

The segment makes clear that MRIs have been available for a long time but are now being studied for their ability to reveal previous "silent" heart attacks.

 

X-mark
Discuss costs? - NOT SATISFACTORY

The medical correspondent gets points for mentioning that MRIs are "expensive" and by extension too costly for use in population screening. But even in such a short segment, given the context, it would have been useful to specify.

Costs are usually $2,000 to $3,000.

The correspondent accurately describes "silent" heart attacks as deadly.

The story does nothing to exaggerate the severity or prevalence of the condition.

The story failed to put this new study into any context of other existing ways of assessing risk. 

It is also important to note that the study was done in patients scheduled for coronary angiography, not just anyone off the street; by definition, this is a high-risk group. 

 

X-mark

The journal article upon which the story is based explained that there is a recently described problem wherein the contrast dye used in the imaging test causes a lung scarring  that is very debilitating. It occurs in some people with kidney disease, and is an important downside mentioned in the journal article but not mentioned in the story.

The segment accurately states that MRIs have been around a long time and that this application is novel, not in clinical use and just now under study.

The segment uses brief data points displayed on the screen to illustrate how common silent heart attacks are and how they elevate the risk of death by 11 times. 

Still, we don't know what percentage of all heart attacks are silent [we are given only a raw number] or what the underlying risk of death is for those who had and didn't have silent heart attacks.

Even a short segment could have added these numbers, even in the brief screen graphic. 

Since no expert is interviewed in the segment, it is impossible to know whether the story relied solely or largely on a news release. 

The researchers in the study in question hold a patent to the machine used in the study. This was never mentioned in the story.  An independent source should have been cited - someone who could answer whether there are other ways of determining risk - and what should be done with this information. 

The segment failed to put the new approach into the context of other methods of predicting risk.

Nuclear imaging can detect some similar findings. Stress testing and resting echocardiogram are also used.

Moreover,  it is not clear that this new information can be used to guide therapy. 

Total Score: 3 of 9 Satisfactory

The U.S. Preventive Services Task Force is considered the gold standard of preventive health recommendations - including on screening tests. It's a good source for journalists and consumers.

Read More

About 70% of the stories reviewed from 2006-9 failed to adequately discuss costs, or to explain how big (or small) are the potential benefits and harms of treatments, tests, products and procedures.

Read More

We have documented a disturbing trend of news stories taking an advocacy stance, promoting certain screening tests outside the boundaries of scientific evidence.

Read More

Stories on new technologies like Cyberknife, DaVinci robotic surgery systems, and proton beam cancer therapy often fail to scrutinize the evidence and/or to discuss the costs involved.

Read More

Rather than suggesting that everyone should be screened for everything, news stories could explain: "All screening tests cause harm; some may do good."

Read More

The first 38 network TV network morning health news stories reviewed in 2009 earned an average score of 1.2 stars. 13 of the 38 stories got ZERO stars.

Read More

Both TIME magazine and BusinessWeek have published terrific stories explaining the importance of the Number Needed to Treat - or NNT.

Read More

Knowing relative risk reduction is like knowing you have a 50% off coupon but not knowing whether it's for a Lexus or a lollipop. Absolute risk reduction tells you what the "coupon" is worth. Read more.

Read More

The website NoFreeLunch.org posts "a database of health care professionals who have pledged to accept no gifts from industry and to rely on non-promotional sources of information."

Read More

To help journalists cover stories responsibly, we post a list of independent experts who state that they do not have financial ties to drug or medical device manufacturers.

Read More

We apply the same ten standardized criteria to the review of every story.

Read More

We have about 30 story reviewers. Each story is reviewed by 3 different people.

Read More

Gary Schwitzer's seven words you shouldn't use in medical news: cure, miracle, breakthrough, promising, dramatic, hope, victim. Read why.

Read More

Our reviewers include two former CNN medical reporters and a former editor of the Washington Post health section.

Read More